Prostate cancer remains one of the most commonly diagnosed malignancies worldwide.
Early diagnosis and curative treatment seem to improve survival in men with unfavourable …

Active surveillance (AS) has been introduced as an observational strategy to delay or avoid
curative treatment without compromising long‐term cancer‐specific survival. The 10 studies …

Purpose Following a prostate cancer diagnosis, patients are faced with a multitude of care
options, the advisability of which is influenced by patient factors and by cancer severity or …

Answer questions and earn CME/CNE Since the dissemination of prostate‐specific antigen
screening, most men with prostate cancer are now diagnosed with localized, low‐risk …

It is worth distinguishing between the two strategies of expectant management for prostate
cancer. Watchful waiting entails administering non‐curative androgen deprivation therapy to …

Importance Active surveillance (AS), per the National Comprehensive Cancer Network
(NCCN) guidelines, is considered for patients with low-risk prostate cancer (PC) and a life …

There is ample evidence that low risk and many cases of low-/intermediate-risk prostate
cancer, are indolent, have little or no metastatic potential, and do not pose a threat to the …

Low‐risk and many cases of low‐intermediate risk prostate cancer have little or no
metastatic potential and do not pose a threat to the patient in his lifetime. Substantial recent …

Approximately one in seven American men will be diagnosed with prostate cancer during
his lifetime, and at least 50% of newly diagnosed patients will present with low-risk disease …

Abstract Background In May 2018, the US Preventive Services Task Force (USPSTF)
recommended prostate cancer (PCa) screening for ages 55–69 be an individual decision …